ÂÜÀòÂÒÂ×

Glenn Rockman has an extensive work experience in various roles and companies. Glenn is the Founder and Managing Partner of Adjuvant Capital, a global life sciences investment company focused on addressing public health challenges. At Adjuvant Capital, Glenn is responsible for identifying and financing new investment opportunities in vaccines, therapeutics, diagnostics, and medical devices.

Glenn is also a Director at X-Vax Technology, Inc., representing Adjuvant Capital's interest as a Series A shareholder and board observer. Additionally, they serve as a Director at VitriVax, a company involved in synthetic biology and the development of recoded vaccines.

Furthermore, Glenn is a Director and Vice-Chair & Secretary at WaterEquity, an organization dedicated to providing access to safe water and sanitation. Glenn is also a Director at Codagenix, Inc., a clinical stage synthetic biology company specializing in constructing live-attenuated vaccines and potential immuno-oncology therapies.

In addition to these roles, Glenn is a Director at RIGHT FUND, Research Investment for Global Health Technology Fund Foundation, an international partnership advancing global health technology and the Korean vaccine industry. Glenn is also a Director at UNIVERCELLS, a company focused on progressive analytical technologies, and InDevR, Inc., a global leader in analytical technologies for vaccine development and manufacturing.

Lastly, Glenn has served as the Secretary-Treasurer of the Global Health Investment Corporation and as a Director at EuBiologics co., Ltd.

Overall, Glenn Rockman's work experience demonstrates their expertise and involvement in various sectors within the life sciences and global health technology industries.

Glenn Rockman obtained their Bachelor of Arts degree from Princeton University, where they attended the Princeton School of Public and International Affairs from 1999 to 2003. Furthermore, in 2001, they pursued a Study Abroad program at The Chinese University of Hong Kong, focusing on Chinese Language (Mandarin), Politics, and History.